Clinical & Magnetic Resonance Research Ctr.

Albuquerque, New Mexico 87131

0 studies enrolling now · 1 studies all time

What they study most

Relapse-Remitting Multiple Sclerosis

Studies at this site

• A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose — Completed